Sustained release preparation of a macrolide compound like tacrolimus
Abstract
Sustained release formulation of a macrolide compound, wherein the time (T63.2%) which is necessary to 63.2% of the maximum amount of macrolide compound is dissolved from 0.7 to 15 hours using a test solution which is 0.005% aqueous solution of hydroxypropyl of pulp adjusted to pH 4.5, wherein the macrolide compound is a tricyclic compound represented by the general formula (I) and a pharmaceutically acceptable salt thereof, wherein each of adjacent pairs of R 1 and R 2, R 3 and R 4, and R 5 and R 6 independently (a) is two adjacent hydrogen atoms, but R2 may also be alkyl groups, or (b) may form another bond formed between the carbon atoms to which they are attached; R 7 is hydrogen atom, hydroxy group, protected hydroxy or alkoxy group, or an oxo group together with R1; R 8 and R 9 are, independently, a hydrogen atom or a hydroxy group; R 10 is a hydrogen atom, alkyl group, alkyl substituted by one or more hydroxy groups, an alkenyl group, an alkenyl group substituted by one or more hydroxy groups, or alkyl substituted with an oxo group; X is an oxo group, (a hydrogen atom and a hydroxy group), (a hydrogen atom and a hydrogen atom), or a group represented by formula -CH 2 O-; Y is an oxo group, (a hydrogen atom and a hydroxy group), (a hydrogen atom and a hydrogen atom), or a group represented by the formula N-NR11R12 or N-OR13, R11 and R12 are, independently, a hydrogen atom, alkyl group, aryl group or a tosyl group; R 13, R 14, R 15, R 16, R 17, R 18, R 19, R 22 and R 23 are, independently, a hydrogen atom or alkyl group; R 24 is an optionally substituted ring system which may contain one or more heteroatoms; n is an integer 1 or 2; and Y with the above definitions R10 and R23 together with the carbon atom to which they are attached, may represent a saturated or unsaturated 5- or 6-membered heterocyclic ring containing nitrogen, sulfur and / or oxygen, optionally substituted by one or more groups selected from the group consisting of alkyl, hydroxy, alkoxy, benzyl, a group of formula "CH2 Si (C6H5), and alkyl groups substituted by one or more hydroxy groups, which forms a solid dispersion composition, wherein the macrolide compound (I) is present in amorphous form which is substantially insoluble in water, where a base is insoluble in water, comprised in the solid dispersion composition, selected from polymers insoluble in water or wax. Log contains 28 claims.
Term
Term ended
Expired 25 March 2019, 7.5 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
95 members in 33 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 7903998 | Japan | A | |
| 18296398 | Japan | A |
Members95
| Document | Office | Kind | |
|---|---|---|---|
| CA2322516A1 | Canada | A1 | |
| WO9949863A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2856399A | Australia | A | |
| NO20004773D0 | Norway | D0 | |
| BR9909201A | Brazil | A | |
| NO20004773L | Norway | L | |
| EP1064942A1 | European Patent Office (EPO) | A1 | |
| TR200002771T2 | Türkiye | T2 | |
| SK14392000A3 | Slovakia | A3 | |
| CZ20003549A3 | Czechia | A3 | |
| ID27825A | Indonesia | A | |
| KR20010042083A | Republic of Korea | A | |
| CN1301157A | China | A | |
| PL343096A1 | Poland | A1 | |
| HU0101237A2 | Hungary | A2 | |
| HUP0101237A1 | Hungary | A1 | |
| IL138466D0 | Israel | D0 | |
| HRP20000707A2 | Croatia | A2 | |
| HK1038185A1 | Hong Kong, China | A1 | |
| ZA200004963B | South Africa | B | |
| US2002044967A1 | United States of America | A1 | |
| AU749623B2 | Australia | B2 | |
| HU0101237A3 | Hungary | A3 | |
| HUP0101237A3 | Hungary | A3 | |
| US6440458B1 | United States of America | B1 | |
| AR023299A1 | Argentina | A1 | |
| EP1064942A4 | European Patent Office (EPO) | A4 | |
| RU2000126836A | Russian Federation | A | |
| KR20030040556A | Republic of Korea | A | |
| US6576259B2 | United States of America | B2 | |
| NZ507211A | New Zealand | A | |
| YU58000A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| RU2214244C2 | Russian Federation | C2 | |
| TW200306867A | Taiwan Province of China | A | |
| US2003235614A1 | United States of America | A1 | |
| TW570814B | Taiwan Province of China | B | |
| KR20040007751A | Republic of Korea | A | |
| EP1421939A1 | European Patent Office (EPO) | A1 | |
| EP1064942B1 | European Patent Office (EPO) | B1 | |
| AT269075T | Austria | T | |
| ATE269075T1 | Austria | T1 | |
| KR100440553B1 | Republic of Korea | B1 | |
| DE69918074D1 | Germany | D1 | |
| PT1064942E | Portugal | E | |
| DK1064942T3 | Denmark | T3 | |
| DE69918074T2 | Germany | T2 | |
| ES2219000T3 | Spain | T3 | |
| JP2004352727A | Japan | A | |
| JP2004354394A | Japan | A | |
| SI1064942T1 | Slovenia | T1 | |
| US6884433B2 | United States of America | B2 | |
| HRP20000707B1 | Croatia | B1 | |
| KR100498765B1 | Republic of Korea | B1 | |
| TWI235068B | Taiwan Province of China | B | |
| KR100505464B1 | Republic of Korea | B1 | |
| US2005169993A1 | United States of America | A1 | |
| JP3714970B2 | Japan | B2 | |
| IL138466A | Israel | A | |
| CN1229111C | China | C | |
| PL193244B1 | Poland | B1 | |
| JP3992031B2 | Japan | B2 | |
| JP2009007369A | Japan | A | |
| US2009074858A1 | United States of America | A1 | |
| RS50164B | Serbia | B | |
| CZ300548B6 | Czechia | B6 | |
| SK286887B6 | Slovakia | B6 | |
| EP1421939B1 | European Patent Office (EPO) | B1 | |
| AT464900TThis record | Austria | T | |
| ATE464900T1 | Austria | T1 | |
| DE69942286D1 | Germany | D1 | |
| EP2198858A1 | European Patent Office (EPO) | A1 | |
| PT1421939E | Portugal | E | |
| ES2343248T3 | Spain | T3 | |
| DK1421939T3 | Denmark | T3 | |
| CA2322516C | Canada | C | |
| MEP30008A | Montenegro | A | |
| JP4622382B2 | Japan | B2 | |
| ME00189B | Montenegro | B | |
| EP1064942B9 | European Patent Office (EPO) | B9 | |
| EP1421939B9 | European Patent Office (EPO) | B9 | |
| NO330578B1 | Norway | B1 | |
| EP2198858B1 | European Patent Office (EPO) | B1 | |
| AT514419T | Austria | T | |
| ATE514419T1 | Austria | T1 | |
| DK1421939T5 | Denmark | T5 | |
| ES2343248T9 | Spain | T9 | |
| PT2198858E | Portugal | E | |
| DK2198858T3 | Denmark | T3 | |
| ES2367294T3 | Spain | T3 | |
| JP4992845B2 | Japan | B2 | |
| US8551522B2 | United States of America | B2 | |
| HU230889B1 | Hungary | B1 | |
| BRPI9909201B1 | Brazil | B1 | |
| RU2214244C9 | Russian Federation | C9 | |
| BRPI9909201B8 | Brazil | B8 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 4002277
Titles2
- German
- RETARDPRÄPARAT MIT MAKROLIDEN WIE TACROLIMUS
- English
- RETARD PREPARATION WITH MACROLIDS SUCH AS TACROLIMUS
Classification
- CPC, 19
- A61K31/453
- A61K31/40
- A61K9/141
- A61K9/143
- A61K9/145
- A61K9/146
- A61K9/1617
- A61K9/1623
- A61K9/1635
- A61K9/1641
- A61K9/1647
- A61K9/1652
- A61K9/4858
- A61K31/407
- A61K31/436
- A61P31/00
- A61P31/04
- A61P37/00
- A61P37/06
- IPC, 28
- A61K31 453
- C07H15 04
- A61K
- A61K9 10
- A61K9 14
- A61K9 16
- A61K9 20
- A61K9 22
- A61K9 48
- A61K9 52
- A61K31 40
- A61K31 405
- A61K31 407
- A61K31 4353
- A61K31 436
- A61K31 706
- A61K47 04
- A61K47 12
- A61K47 14
- A61K47 26
- A61K47 32
- A61K47 36
- A61K47 38
- A61K47 40
- A61P31 00
- A61P37 06
- C07D498 18
- G01N33 15